和邦生物：8月19日召开董事会会议

Group 1 - The core point of the article is that Hebang Biotechnology (SH 603077) held its 25th meeting of the 6th board of directors on August 19, 2025, to review the semi-annual report for 2025 [1] - For the first half of 2025, the revenue composition of Hebang Biotechnology is as follows: Chemical industry accounts for 90.71%, photovoltaic glass industry accounts for 17.8%, mineral industry accounts for 6.75%, and internal deductions account for -15.26% [1] - As of the time of reporting, the market capitalization of Hebang Biotechnology is 16.8 billion yuan [1]